No Data
No Data
Citi: Maintains a "buy" rating on sh pharma with a target price cut to 15.3 Hong Kong dollars.
Citi released a research report stating that it maintains a 'buy' rating for Shanghai Pharma (02607), with a 6%, 5%, and 5% downward revision of earnings forecasts for each year from 2024 to 2026, reflecting challenges faced by pharmacies and narrowing profit margins in the distribution business. The target price for the listed in Hong Kong shares is reduced from 16.2 Hong Kong dollars to 15.3 Hong Kong dollars. The report indicates that the company's third-quarter revenue increased by 8% year-on-year to 70 billion yuan, affected by a decrease in gross margin, with net profit dropping 6% year-on-year to 1.1 billion yuan, and the gross margin for the period decreased to 10%, compared to 10.6% in the same period of the previous fiscal year. The company's management expects to launch one innovative drug next year.
Citigroup: Reiterate a 'buy' rating for Yue Yuen Ind, with a target price raised to 20.3 Hong Kong dollars
Citi released a research report stating that after Yue Yuen Ind (00551) announced its third-quarter performance, it raised its profit forecast for 2024 to 2026 by 15% to 17%, and raised the target price by 16% from HK$17.5 to HK$20.3. It also reiterated a "buy" rating, with an estimated dividend yield of around 8% for this year. Citigroup indicated that Yue Yuen's performance for the first nine months showed a better-than-expected expansion trend in the gross margin of its footwear manufacturing business (MFG). The group's manufacturing revenue in October increased by 21.3% year-on-year, although it slowed down compared to the previous month. However, the growth rate is still higher than the average level for the first ten months.
Trump's 'Super Week' comes to an end. Will the 'reinflation' trade take over?
The trading market driven by the usa election will continue to be a significant feature of the market after the end of the trade.
The 'Trump trade' remains hot, with the s&p 500 breaking 6,000 points for the first time, and Tesla surging 9%.
As the US stock market continues to rise after the election, the Dow Jones Industrial Average surged over 300 points on Monday, closing above 44,000 for the first time, setting a new record high. The Dow rose 304 points to 44,293.69, up 0.69%. The S&P 500 index rose 0.1% to close at 6,001.35, surpassing 6,000 for the first time, reaching a record high. However, the Nasdaq Composite Index hovered near the flatline, rising 0.06% to 19,298.76. JPMorgan and
Citigroup Options Spot-On: On November 11th, 182.86K Contracts Were Traded, With 2.48 Million Open Interest
Large-Cap Banks Set to Benefit From Capital Market Acceleration After Trump Win, Morgan Stanley Says
No Data
No Data
0FaFa0 OP : Thank you for the encouragement and support.
溫馨提示 : Can't grasp the strength of Tsla, Nvda, and Bitcoin updates. Been busy and prosperous for the past 4 years.
EbdAidivn : If you held on to Coinbase pre 125 give yourself a pat on the back